News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
242,023 Results
Type
Article (14635)
Company Profile (31)
Press Release (227355)
Section
Business (75342)
Career Advice (721)
Deals (12669)
Drug Delivery (33)
Drug Development (27364)
Employer Resources (20)
FDA (5420)
Job Trends (5263)
News (121404)
Policy (9735)
Tag
Academia (632)
Accelerated approval (6)
Adcomms (4)
Allergies (41)
Alliances (12410)
ALS (46)
Alzheimer's disease (428)
Antibody-drug conjugate (ADC) (93)
Approvals (5604)
Artificial intelligence (77)
Autoimmune disease (29)
Automation (2)
Bankruptcy (103)
Best Places to Work (4117)
BIOSECURE Act (1)
Biosimilars (59)
Biotechnology (24)
Bladder cancer (66)
Brain cancer (23)
Breast cancer (253)
Cancer (1613)
Cardiovascular disease (139)
Career advice (564)
Career pathing (4)
CAR-T (57)
CDC (8)
Cell therapy (167)
Cervical cancer (15)
Clinical research (24273)
Collaboration (325)
Company closure (1)
Compensation (243)
Complete response letters (7)
COVID-19 (701)
CRISPR (20)
C-suite (91)
Cystic fibrosis (30)
Data (2370)
Decentralized trials (1)
Depression (31)
Diabetes (186)
Diagnostics (2040)
Digital health (13)
Diversity (2)
Diversity, equity & inclusion (6)
Drug discovery (44)
Drug pricing (57)
Duchenne muscular dystrophy (55)
Earnings (52354)
Editorial (15)
Employer branding (5)
Employer resources (16)
Events (38943)
Executive appointments (116)
FDA (6428)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (12)
Funding (275)
Gene editing (43)
Generative AI (3)
Gene therapy (158)
GLP-1 (354)
Government (1149)
Grass and pollen (1)
Guidances (330)
Healthcare (5538)
HIV (30)
Huntington's disease (22)
IgA nephropathy (19)
Immunology and inflammation (68)
Immuno-oncology (11)
Indications (21)
Infectious disease (795)
Inflammatory bowel disease (56)
Inflation Reduction Act (5)
Influenza (39)
Intellectual property (40)
Interviews (91)
IPO (7166)
IRA (17)
Job creations (1352)
Job search strategy (540)
Kidney cancer (4)
Labor market (34)
Layoffs (135)
Leadership (4)
Legal (2188)
Liver cancer (26)
Longevity (2)
Lung cancer (251)
Lymphoma (157)
Machine learning (2)
Management (4)
Manufacturing (124)
MASH (62)
Medical device (4302)
Medtech (4319)
Mergers & acquisitions (5812)
Metabolic disorders (453)
Multiple sclerosis (42)
NASH (6)
Neurodegenerative disease (89)
Neuropsychiatric disorders (29)
Neuroscience (773)
NextGen: Class of 2026 (1550)
Non-profit (1168)
Now hiring (11)
Obesity (203)
Opinion (53)
Ovarian cancer (61)
Pain (45)
Pancreatic cancer (75)
Parkinson's disease (64)
Partnered (4)
Patents (70)
Patient recruitment (81)
Peanut (14)
People (11584)
Pharmaceutical (9)
Pharmacy benefit managers (6)
Phase I (6540)
Phase II (10050)
Phase III (9222)
Pipeline (2420)
Policy (58)
Postmarket research (1173)
Preclinical (2594)
Press Release (25)
Prostate cancer (55)
Psychedelics (9)
Radiopharmaceuticals (81)
Rare diseases (170)
Real estate (1654)
Recruiting (7)
Regulatory (7510)
Reports (25)
Research institute (551)
Resumes & cover letters (112)
Rett syndrome (10)
RNA editing (6)
RSV (37)
Schizophrenia (55)
Series A (45)
Series B (45)
Sickle cell disease (29)
Special edition (10)
Spinal muscular atrophy (43)
Sponsored (9)
Startups (831)
Stomach cancer (2)
Supply chain (22)
Tariffs (21)
The Weekly (16)
Vaccines (262)
Venture capital (17)
Weight loss (148)
Women's health (17)
Worklife (3)
Date
Today (88)
Last 7 days (287)
Last 30 days (622)
Last 365 days (10331)
2026 (409)
2025 (10442)
2024 (11771)
2023 (13130)
2022 (17173)
2021 (17520)
2020 (16450)
2019 (13136)
2018 (9727)
2017 (8680)
2016 (7229)
2015 (8943)
2014 (6896)
2013 (5789)
2012 (38164)
2011 (22663)
2010 (5610)
Location
Africa (268)
Alabama (18)
Arizona (69)
Arkansas (4)
Asia (15041)
Australia (2087)
California (3578)
Canada (1061)
China (344)
Colorado (145)
Connecticut (165)
Delaware (131)
Europe (34725)
Florida (468)
Georgia (107)
Idaho (9)
Illinois (288)
India (11)
Indiana (201)
Iowa (4)
Japan (162)
Kansas (70)
Kentucky (15)
Louisiana (13)
Maine (32)
Maryland (366)
Massachusetts (2510)
Michigan (81)
Minnesota (179)
Mississippi (2)
Missouri (44)
Montana (7)
Nebraska (7)
Nevada (37)
New Hampshire (26)
New Jersey (1295)
New Mexico (3)
New York (943)
North Carolina (451)
North Dakota (3)
Northern California (1870)
Ohio (73)
Oklahoma (1)
Oregon (4)
Pennsylvania (726)
Puerto Rico (3)
Rhode Island (6)
South America (397)
South Carolina (12)
Southern California (1392)
Tennessee (41)
Texas (540)
United States (12748)
Utah (95)
Virginia (63)
Washington D.C. (15)
Washington State (280)
Wisconsin (23)
242,023 Results for "13".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Vaxart to Participate in the Global BioInnovation Forum on January 13, 2026
January 9, 2026
·
1 min read
Cancer
Bayer Makes Potential $1.3B Cancer Bet in Kumquat Deal
For $1.3 billion in aggregate—including upfront and milestone payments—Bayer will get exclusive global access to Kumquat Biosciences’ small-molecule KRAS G12D blocker.
August 12, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Theralase(R) Closes $1.3 M Non-Brokered Private Placement
December 23, 2025
·
5 min read
Press Releases
Kymera Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13
January 6, 2026
·
1 min read
Press Releases
Edgewise Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026
January 6, 2026
·
1 min read
Press Releases
BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - January 13, 2026
January 14, 2026
·
1 min read
Press Releases
Rapid Medical™ Completes Enrollment in DISTALS Trial Evaluating TIGERTRIEVER 13™ for Distal Vessel Occlusions
December 10, 2025
·
2 min read
Press Releases
MBX Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13
December 16, 2025
·
1 min read
Press Releases
Sitryx to participate in upcoming healthcare investor conferences - November 13, 2025
November 14, 2025
·
1 min read
Press Releases
Santhera Closes USD 13 Million Royalty Monetization Agreement
November 5, 2025
·
2 min read
1 of 24,203
Next
